About
Principal in Monograph's London office leading investments in therapeutics and pharmaceutical services. Board observer at Elevara Medicines, Maxion Therapeutics and Prolynx; previously an Engagement Manager at L.E.K. Consulting.
Experience
- Monograph CapitalPrincipalcurrent2026 — presentLondon Area, United Kingdom
- Monograph CapitalInvestment Manager2025 — 2026
- Monograph CapitalAssociate2022 — 2025Greater London, England, United Kingdom
- Elevara Medicines LimitedFounding team: Director of Corporate Development2025London Area, United Kingdom
- Maxion TherapeuticsCorporate Development (interim)2024
- World Economic ForumProject Fellow - Global Health & Healthcare Industry2022
- L.E.K. ConsultingEngagement Manager2021 — 2022Greater London, England, United Kingdom
- L.E.K. ConsultingConsultant, Life Sciences2019 — 2021London Area, United Kingdom
- L.E.K. ConsultingSenior Life Sciences Specialist2018 — 2019London Area, United Kingdom
- L.E.K. ConsultingLife Sciences Specialist2016 — 2018London, United Kingdom
- CHUV | Lausanne university hospitalResearch Assistant2010Lausanne, Switzerland
- MedtronicIntern2008Tolochenaz, Switzerland
Education
- UCLDoctor of Philosophy (Ph.D.), Oncology and Cancer Biology2012 — 2016
- Imperial College LondonMaster’s Degree, Immunology2011 — 2012
- Imperial College LondonBachelor’s Degree, Biochemistry2008 — 2011
- Harvard Business SchoolHBX; "Core: Credential of Readiness"2015
- International School of Lausanne2004 — 2008
- American School of Warsaw2001 — 2003
Skills & more
Strategy consultingDue DiligenceResearch and Development (R&D)Data AnalysisProject Management Office (PMO)ImmunologyBiotechnologyCancer BiologyScientific CommunicationsAdvisory BoardsScience CommunicationCancer Research
+5 more
Orphan DrugsPharma & Life SciencesMicrosoft OfficePricing & reimbursement analysisContract ServicesLanguages English · Turkish
From Melisa's professional profile.
Same school
Also attended UCL272
André DuboisInvestor at Index VenturesFrédérique DameInvestor at GV (Google Ventures)Jonas VetterleInvestor at Moonfire VenturesMarie FerriInvestor at DaphniElena PantaziPartner & Head of Platform at NorthzoneGiovanni MariggiInvestor at Medicxi
+ 266 more
Also attended Imperial College London327
Deji SasegbonVP, Platform & Portfolio Operations at EchoVC PartnersMadison LenormandInvestor at DaphniPauline BoucherInvestor at DaphniLoubaba El AyoubiInvestor at NorthzoneGiovanni MariggiInvestor at MedicxiFrancois PrinslooInvestor at Medicxi
+ 321 more
Also attended Harvard Business School1,818
Brad GerstnerFounder & CEO of Altimeter CapitalAileen LeeFounder & Managing Partner of Cowboy VenturesJim BreyerFounder & CEO of Breyer CapitalTim DraperFounder of Draper AssociatesMike Maples JrCo-founding Partner at FloodgateMamoon HamidPartner at Kleiner Perkins
+ 1,812 more
Shared employers
Also worked at Monograph Capital11
Tim FunnellPartner at Monograph Capital PartnersCharles ConnPartner at Monograph Capital PartnersFreddie DearPrincipal at Monograph Capital PartnersJaideep DudaniPrincipal at Monograph Capital PartnersCharlie ZhouInvestment Manager at Monograph Capital PartnersMichelle HeInvestment Manager at Tin Alley Ventures
+ 5 more
Also worked at Elevara Medicines Limited2
Also worked at Maxion Therapeutics3
Also worked at L.E.K. Consulting116
Chris BischoffInvestment Team at General CatalystMattias LjungmanInvestor at Moonfire VenturesJessica SchultzPartner at NorthzoneFrancois PrinslooInvestor at MedicxiMiranda GuerreroExecutive Assistant at Sapphire VenturesStacey HeroInvestor at Third Rock Ventures
+ 110 more
Colleagues at Monograph Capital Partners
Bonnie van Wilgenburg
Principal at Monograph Capital Partners
Brandi O'Donnell
Chief of Staff & Executive Assistant at Monograph Capital Partners
Brandi O’Donnell
Chief of Staff & EA at Monograph Capital Partners
Charles Conn
Partner at Monograph Capital Partners
Charlie Zhou
Investment Manager at Monograph Capital Partners
Daniel Schwarz
Chief Financial Officer at Monograph Capital Partners
Fred Cohen
Partner and Chairman at Monograph Capital Partners
Freddie Dear
Principal at Monograph Capital Partners





















.jpg)





